These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy. Kwan KG; Kapoor A Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804 [TBL] [Abstract][Full Text] [Related]
25. [The pathologist's role in the neoadjuvant strategy of renal-cell carcinoma]. Leroy X; Edeline J; Rioux-Leclercq N Ann Pathol; 2011 Dec; 31(6):466-71. PubMed ID: 22172119 [TBL] [Abstract][Full Text] [Related]
26. Patterns of failure following surgical resection for malignant pleural mesothelioma. Jänne PA; Baldini EH Thorac Surg Clin; 2004 Nov; 14(4):567-73. PubMed ID: 15559064 [TBL] [Abstract][Full Text] [Related]
27. Integration of surgery and systemic therapy for renal cell carcinoma. Kenney PA; Wood CG Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764 [TBL] [Abstract][Full Text] [Related]
28. Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors. Chan HY; Grossman AB; Bukowski RM Adv Ther; 2010 Aug; 27(8):495-511. PubMed ID: 20623346 [TBL] [Abstract][Full Text] [Related]
36. [The medical treatment of renal cancer in adults]. Sculier JP Rev Med Brux; 1989 May; 10(5):190-6. PubMed ID: 2662317 [TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant treatment in advanced renal cell carcinoma: current situation and future perspectives. Timsit MO; Albiges L; Méjean A; Escudier B Expert Rev Anticancer Ther; 2012 Dec; 12(12):1559-69. PubMed ID: 23253222 [TBL] [Abstract][Full Text] [Related]